MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202411025463 A) filed by Athena Pharmaceutiques Sas, Louveciennes, France, on March 28, 2024, for 'lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof.'
Inventor(s) include Mahendra Baliram Chaudhari; Omprakash Doulatram Chandwani; Nitin Pandharinath Nehete; Amol Yuvraj Chaudhari; and Anita Kunal Shahane.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a lisdexamfetamine dimesylate orodispersible tablet and a process for preparation thereof. The lisdexamfetamine dimesylate orodispersible tablet comprises: co-sifting lisdexamfetamine dimesylate; a binder and a diluent; dry mixing and blending the sifted lisdexamfetamine dimesylate, the binder and the diluent to form a blended dry mix; co-sifting and blending the diluent, a cushioning agent, a disintegrating agent, a sweetener, and an antistatic agent to prepare an intermediate blend; blending the blended dry mix and the intermediate blend; lubricating the blended dry mix and the intermediate blend to form ready to compress drug granules; and compressing the ready to compress drug granules to form compressed lisdexamfetamine dimesylate orodispersible tablet."
Disclaimer: Curated by HT Syndication.
